The economic impact of pediatric RSV-related lower respiratory tract infection in Germany: evidence from the PAPI study

BACKGROUND: Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infections (LRTI) in infants and young children. While considerable research has described the clinical burden and direct medical costs of RSV in Germany, the broader economic impact remains poorly understood, particularly the burden on affected families and productivity losses associated with parental work absence. METHODS: The prospective, multicenter PAPI study was conducted across 12 hospitals and five pediatric practices in Germany during the 2021-2022 and 2022-2023 RSV seasons. Children under 24 months presenting with lower respiratory tract infections were tested for RSV. Health care resource use, parental expenses, and absenteeism were assessed through questionnaires and follow-up interviews. The human capital approach was used to estimate productivity losses. RESULTS: Of 1,607 hospitalized children, 918 (57.1%) tested positive for RSV and 714 were included in the analysis. In the outpatient setting, 286 of 1,442 cases (19.8%) were RSV-positive, with 250 included in the analysis. Among hospitalized RSV cases, 91.3% required additional primary care visits. Parental work loss was reported in 64.3% of hospitalized and 37.5% of outpatient cases. Mean productivity losses were €1,865 for hospitalized cases and €1,484 for outpatient cases associated with parental work loss. Productivity losses were higher for toddlers (aged 12-23 months) than infants (0-11 months), with hospitalized toddlers showing the highest mean loss of €2,584 per case involving parental work absence. CONCLUSIONS: This study demonstrates that RSV infections in children under two years impose a substantial economic burden on the German health care system and parents. The findings provide critical evidence to support decision-making on preventive strategies aimed at reducing RSV-related morbidity and its economic consequences in Germany.

Authors

Institutions

Publication Details

Journal
Journal of Medical Economics
Published
2026-08-18
DOI
https://doi.org/10.1080/13696998.2026.2714652
Primary Topic
Respiratory viral infections research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The economic impact of pediatric RSV-related lower respiratory tract infection in Germany: evidence from the PAPI study

Rolf Kramer, Oliver Damm, Moritz Wick, Mathieu Bangert et al.
Journal of Medical Economics
Respiratory viral infections research
article

The economic impact of pediatric RSV-related lower respiratory tract infection in Germany: evidence from the PAPI study

Rolf Kramer, Oliver Damm, Moritz Wick, Mathieu Bangert, Christine Happle, Martin Wetzke, Mareike Meier-Maiwald, David Twardella, Frank Eberhardt, Grit Barten-Neiner, Jessica Baehre
article en

Abstract

BACKGROUND: Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infections (LRTI) in infants and young children. While considerable research has described the clinical burden and direct medical costs of RSV in Germany, the broader economic impact remains poorly understood, particularly the burden on affected families and productivity losses associated with parental work absence. METHODS: The prospective, multicenter PAPI study was conducted across 12 hospitals and five pediatric practices in Germany during the 2021-2022 and 2022-2023 RSV seasons. Children under 24 months presenting with lower respiratory tract infections were tested for RSV. Health care resource use, parental expenses, and absenteeism were assessed through questionnaires and follow-up interviews. The human capital approach was used to estimate productivity losses. RESULTS: Of 1,607 hospitalized children, 918 (57.1%) tested positive for RSV and 714 were included in the analysis. In the outpatient setting, 286 of 1,442 cases (19.8%) were RSV-positive, with 250 included in the analysis. Among hospitalized RSV cases, 91.3% required additional primary care visits. Parental work loss was reported in 64.3% of hospitalized and 37.5% of outpatient cases. Mean productivity losses were €1,865 for hospitalized cases and €1,484 for outpatient cases associated with parental work loss. Productivity losses were higher for toddlers (aged 12-23 months) than infants (0-11 months), with hospitalized toddlers showing the highest mean loss of €2,584 per case involving parental work absence. CONCLUSIONS: This study demonstrates that RSV infections in children under two years impose a substantial economic burden on the German health care system and parents. The findings provide critical evidence to support decision-making on preventive strategies aimed at reducing RSV-related morbidity and its economic consequences in Germany.

Journal of Medical EconomicsVol. 29(1)
Fakultní nemocnice Bulovka (CZ), Medizinische Hochschule Hannover (DE), Kinderkrankenhaus auf der Bult (DE), Sanofi (Germany) (DE), Sanofi (Mexico) (MX)
Openalex Percentile: Top 9%
Respiratory viral infections research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.